[Combination of antifungal chemotherapeutic agents in experimental candidiasis in mice].
For the valuation of therapeutical activity of many new recent antifungal drugs, these were employed in the various possible associations in the experimental candidosis of the mouse. From the results obtained calculated on the survivance percentage, was concluded that the best antifungal is the 5 fluorocytosine + amphotericin B association.
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy*; D003022:Clotrimazole / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005437:Flucytosine / Q000627:therapeutic use; D051379:Mice
D000935:Antifungal Agents; D000666:Amphotericin B; D005437:Flucytosine; D003022:Clotrimazole
Associazione di chemioterapici antifunginei nella candidosi sperimentale del topo.